| Beef Cattle
Welcome
to the Novartis Animal Health Beef Resource Center. Start here
for information about common diseases of
beef cattle, how those diseases harm performance and profits, and
how Novartis Animal Health products can
help prevent or treat disease in your cattle operation. Select
any disease or
product
below
to
learn
more, or use
the menu at right for more information.
Working with your veterinarian to develop a Beef
Herd Health Program may be one of the most beneficial steps
you can take to keep your operation profitable. He or she has
the education and experience necessary to advise you on disease
and management problems.
Novartis has a full line of products to give you safe, effective
disease protection that can make a difference in your overall herd
health program.
|
5 costly diseases of beef cattle |
Novartis Animal Health
solutions |
| 1. Respiratory
diseases
|
| Viral diseases (Type
1 & Type 2 BVD, BRSV, IBR, PI3) |
Vira
Shield®,
Arsenal® 4.1
|
| Bacterial diseases
(H. somnus) |
Vira
Shield® (includes
combos with H.
somnus) |
| 2. Lameness |
| Footrot |
Fusogard® |
| 3. Reproductive
diseases |
| Bacterial diseases
(vibrio, lepto) |
ReproSTAR VL5 HB
Vib
Shield® Plus L5
|
| Viral diseases (IBR,
Type 1 & Type 2 BVD) |
Vira
Shield® |
| 4. Scours |
| Rotavirus, coronavirus |
Scour Bos™ 4 |
| Rotavirus, coronavirus, E.
coli, C. perfringens Type C |
Scour
Bos® 9 |
| E. coli |
Bovine
Pili Shield™,
Bovine Ecolizer
|
| C. perfringens Type C |
Bovine
Ecolizer+C 20
Clostratox® BCD
[pdf]
Clostratox® C
and Ultra C 1300 [pdf]
Clostri
Shield® BCD [pdf]
|
| 5. Clostridial diseases |
| C. chauvoei (blackleg) |
Clostri Shield® 7 |
| C. septicum (malignant
edema) |
Clostri Shield® 7 |
| C. novyi (black disease) |
Clostri Shield® 7 |
| C. sordelii (gas gangrene) |
Clostri Shield® 7 |
| Tetanus |
Antitox Tet™ |
| C. perfringens Type A |
Clostridium Perfringens Type A Toxoid |
C. perfringens Types
B, C & D
(enterotoxemia) |
Clostri
Shield® 7
Clostri
Shield® BCD [pdf]
Clostratox® BCD
[pdf]
Clostratox® C
and Ultra C 1300 [pdf]
|
|
